SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Maurer Matthew J.)
 

Sökning: WFRF:(Maurer Matthew J.) > Molin Daniel > Minimal relapse ris...

  • Jakobsen, Lasse H.Aalborg University,Aalborg University Hospital,Aalborg Univ Hosp, Dept Hematol, Sdr Skovvej 15, DK-9000 Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark.,Oslo Univ Hosp, Dept Oncol, Oslo, Norway.;Oslo Univ Hosp, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway. (författare)

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy : an international study of 264 real-world patients

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • 2020-02-04
  • Wiley,2020
  • 11 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:a30ecf36-197d-4ab3-8d1e-d99d36565fd7
  • https://lup.lub.lu.se/record/a30ecf36-197d-4ab3-8d1e-d99d36565fd7URI
  • https://doi.org/10.1111/bjh.16425DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-425116URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163706URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142864023URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Funding Agencies|US National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Danish Cancer SocietyDanish Cancer Society; Danish North Jutland Region
  • Non-endemic Burkitt lymphoma (BL) is a rare germinal centre B-cell-derived malignancy with the genetic hallmark of MYC gene translocation and with rapid tumour growth as a distinct clinical feature. To investigate treatment outcomes, loss of lifetime and relapse risk in adult BL patients treated with intensive immunochemotherapy, retrospective clinic-based and population-based lymphoma registries from six countries were used to identify 264 real-world patients. The median age was 47 years and the majority had advanced-stage disease and elevated LDH. Treatment protocols were R-CODOX-M/IVAC (47%), R-hyper-CVAD (16%), DA-EPOCH-R (11%), R-BFM/GMALL (25%) and other (2%) leading to an overall response rate of 89%. The two-year overall survival and event-free survival were 84% and 80% respectively. For patients in complete remission/unconfirmed, the two-year relapse risk was 6% but diminished to 0·6% for patients reaching 12 months of post-remission event-free survival (pEFS12). The loss of lifetime for pEFS12 patients was 0·4 (95% CI: −0·7 to 2) months. In conclusion, real-world outcomes of adult BL are excellent following intensive immunochemotherapy. For pEFS12 patients, the relapse risk was low and life expectancy similar to that of a general population, which is important information for developing meaningful follow-up strategies with increased focus on survivorship and less focus on routine disease surveillance.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Ellin, FredrikLund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lymfom - Klinisk forskning,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lymphoma - Clinical Research,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Clin Sci Lund, Oncol, Lund, Sweden.(Swepub:lu)med-fke (författare)
  • Smeland, Knut B.Oslo university hospital,Oslo Univ Hosp, Dept Oncol, Oslo, Norway. (författare)
  • Wästerlid, ToveKarolinska Institutet(Swepub:lu)med-twl (författare)
  • Christensen, Jacob H.Odense University Hospital,Odense Univ Hosp, Dept Hematol, Odense, Denmark. (författare)
  • Jørgensen, Judit M.Aarhus University Hospital,Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark.,Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA. (författare)
  • Josefsson, Pär L.Herlev Hospital,Herlev Hosp, Dept Hematol, Herlev, Denmark. (författare)
  • Øvlisen, Andreas K.Aalborg University Hospital,Aalborg University,Aalborg Univ Hosp, Dept Hematol, Sdr Skovvej 15, DK-9000 Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark. (författare)
  • Holte, HaraldOslo university hospital,Roskilde Sygehus, Dept Hematol, Roskilde, Denmark. (författare)
  • Blaker, Yngvild N.Oslo university hospital,Oslo Univ Hosp, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway.;Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway. (författare)
  • Grauslund, Jacob H.Zealand University Hospital (författare)
  • Bjørn, JonCopenhagen University Hospital,Rigshosp, Dept Hematol, Copenhagen, Denmark. (författare)
  • Molin, Daniel,1969-Uppsala universitet,Uppsala University,Experimentell och klinisk onkologi,Uppsala Univ, Sweden(Swepub:uu)danimoli (författare)
  • Lagerlöf, IngemarLinköpings universitet,Linköping University,Linköping Univ, Dept Med & Hlth Sci, Div Drug Res, Linköping, Sweden.,Avdelningen för läkemedelsforskning,Medicinska fakulteten(Swepub:liu)n/a (författare)
  • Smedby, Karin E.Karolinska Institutet (författare)
  • Colvin, KatherineSir Charles Gairdner Hospital,Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia. (författare)
  • Thanarajasingam, GitaMayo Clinic Minnesota,Mayo Clin, Div Hematol, Rochester, MN USA. (författare)
  • Maurer, Matthew J.Mayo Clinic Minnesota (författare)
  • Habermann, Thomas M.Mayo Clinic Minnesota,Mayo Clin, Div Hematol, Rochester, MN USA. (författare)
  • Song, Kevin W.BC Canc, Ctr Lymphoid Canc, Leukemia BMT Program BC, Vancouver, BC, Canada. (författare)
  • Zhu, Katie Y.BC Canc, Ctr Lymphoid Canc, Leukemia BMT Program BC, Vancouver, BC, Canada. (författare)
  • Gerrie, Alina S.BC Canc, Ctr Lymphoid Canc, Leukemia BMT Program BC, Vancouver, BC, Canada. (författare)
  • Cheah, Chan Y.University of Western Australia, Crawley,Sir Charles Gairdner Hospital,Sir Charles Gairdner Hosp, Dept Hematol, Nedlands, WA, Australia.;Pathwest Lab Med WA, Dept Hematol, Nedlands, WA, Australia.;Univ Western Australia, Med Sch, Crawley, Australia. (författare)
  • El-Galaly, Tarec C.Aalborg University,Aalborg University Hospital,Aalborg Univ Hosp, Dept Hematol, Sdr Skovvej 15, DK-9000 Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark. (författare)
  • Aalborg UniversityAalborg University Hospital (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:British Journal of Haematology: Wiley189:4, s. 661-6710007-10481365-2141

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy